comparemela.com

Latest Breaking News On - மெட்ரான் பகுப்பாய்வு - Page 1 : comparemela.com

The Macron s are returning to Greece - Greek City Times

Economy, unemployment top concerns for Greeks according to new poll

The economy and unemployment are veering to the top of the list of the concerns of citizens as the COVID-19 epidemic begins receding and as Greece’s vaccine rollout proceeds at a rapid pace. According to a Metron Analysis poll broadcast on MEGA television, 33 percent of Greeks believe that the most important issue the country faces is “the coronavirus and healthcare”, but that represents a 16 percentage point drop since April. Now, the pandemic and its repercussions are virtually in a tie with the economy (31 percent, a four percentage point drop since April). The problem of unemployment is also raising greater concerns as 11 percent of respondents viewed it as a critical problem as compared to seven percent last month.

As pandemic recedes, Greeks turn their attention to economy, unemployment - Ειδήσεις - νέα

The PM and the government do not want to lose as a result of the labour bill all that it did not lose as a result of the protracted lockdown and from the back-and-forth openings and closures of the market.

ND enjoys 14%-point lead over SYRIZA in latest Metron Analysis opinion poll

Thirty Percent of Greeks Say They Will Shun Vaccine When Available

Thirty Percent of Greeks Say They Will Shun Vaccine When Available Credit: Bodossaki Foundation According to a recent poll by Pulse, on behalf of Skai television, up to 30 percent, of Greek citizens say that they will not receive the vaccine for the coronavirus. Despite the nonstop pandemic-related economic and social problems and challenges of this year, a sizable amount of the population, which may be mirrored in other countries as well, has such severe reservations about the shot that they would refuse to take it, according to the survey. The vaccines, including one from Pfizer/BioNTech, another from Moderna, which both use RNA as their basis, and a third, developed by Oxford University/AstraZeneca, may all the available to the general public by the early months of 2021, but a sizable minority in society are not convinced of their efficacy.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.